Longitudinally extensive myelopathy as a paraneoplastic manifestation of small cell lung carcinoma: an atypical clinical presentation
Abstract
Case Presentation: A 65-year-old female, former smoker, presented with a subacute progression of pseudoathetosis evolving to severe sensory ataxia, paraparesis, and inability to walk. Neurological examination showed generalized athetosis predominantly in the upper limbs, worsening with eye closure, a markedly positive Romberg sign with immediate falling, tabetic gait dependent on visual input, diffuse areflexia, and bilateral extensor plantar responses. Brain magnetic resonance imaging was normal. Cervical and thoracic spine MRI revealed a longitudinally extensive lesion restricted to the posterior columns without spinal cord compression, mimicking subacute combined degeneration. Electroneuromyography demonstrated severe axonal sensory polyneuropathy in all four limbs, suggesting concomitant peripheral somatosensory involvement. Differential diagnoses included vitamin B12 deficiency, neuromyelitis optica, and idiopathic autoimmune myelitis. Serum testing was positive for onconeural antibodies Anti-Hu and Anti-Yo. Chest CT and PET-CT identified a hypermetabolic lesion in the left lower lobe with mediastinal lymphadenopathy (T1cN2a). Small cell lung carcinoma was confirmed by guided biopsy. The patient received intravenous methylprednisolone pulse therapy (1 g/day for seven days), resulting in partial clinical improvement, with approximately 30% reduction in pseudoathetosis and mild distal sensory recovery in the lower limbs. Monthly intravenous immunoglobulin therapy was subsequently initiated, with partial neurological recovery. Discussion: Paraneoplastic neurological syndromes are immune-mediated disorders associated with systemic malignancies and may precede cancer diagnosis. In small cell lung carcinoma, they occur in approximately 3–5% of cases and can affect both the central and peripheral nervous systems. Anti-Hu antibodies are strongly associated with sensory neuropathy or encephalomyelitis in this context, whereas Anti-Yo is classically linked to paraneoplastic cerebellar degeneration and is rarely associated with lung cancer. Paraneoplastic myelopathy is uncommon and may mimic subacute combined degeneration when posterior columns are selectively involved. Concomitant sensory polyneuropathy suggests diffuse immune-mediated involvement of the sensory ganglion axis. Dual Anti-Hu/Anti-Yo positivity may reflect an expanded autoimmune response against intracellular neuronal antigens, predominantly mediated by cytotoxic T lymphocytes, which may limit response to immunotherapy alone and highlights the importance of early oncologic treatment. Final Comments: This case expands the phenotypic spectrum of neurological manifestations associated with small cell lung carcinoma, highlighting the importance of paraneoplastic investigation in longitudinally extensive myelopathies with predominantly sensory involvement, especially when associated with peripheral neuropathy and positive onconeural serology.